Closing the Vacancy Gap: The Case for Using a Contract Sales Organization To Manage Field-Force Vacancies

An open pharmaceutical sales territory can create a longer-lasting commercial gap than the vacancy itself. Prescriber access can decline, sample cadence can slip and neighboring representatives can be stretched thin. With recruiting, onboarding and ramp-up, the impact may extend for months after a replacement is identified. In one illustrative specialty pharma scenario, the white paper estimates that a six-month vacancy-and-ramp cycle could result in approximately $700,000 in lost revenue before a new representative reaches full productivity.

A contract sales organization (CSO) offers a different approach to pharmaceutical field-force vacancy management. Deployment-ready representatives can restore coverage while the CSO manages recruiting, employment and day-to-day supervision. The structure matters: The biopharmaceutical company owns the strategy, approved messaging and performance expectations, while the CSO owns how the work gets done. This separation can help address co-employment considerations while turning territory coverage into a measurable service governed by defined key performance indicators (KPIs), service levels and reporting.

This white paper examines the economics of uncovered territories, the legal and human resources considerations of CSO programs and the operating principles that can help biopharmaceutical companies maintain commercial continuity when field-force vacancies occur.